| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |